Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Cue Biopharma, Inc. CUE

Full chart Compare
Set alert

Price alert · CUE

All alert types
20.86 USD +1.44 (+7.42%)

At closeNov 3, 2026, 4:01 PM EST

20.86 0.00 0.00%

After hours · Nov 3, 4:01 PM ET

19.01 Day range 21.00
5.31 52-week range 37.84
YTD
+127.98%
1 year
-3.16%

Financial health

Altman Z-Score

-29.92 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

2 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

D+1 / 5 overall

  • DCF 1
  • Return on Equity 1
  • Return on Assets 1
  • Debt / Equity 1
  • P/E 1
  • P/B 1

Valuation

P/E -1.1×
FY 2016: -31.4×FY 2017: -10.3×FY 2018: -2.4×FY 2019: -9.6×FY 2020: -8.0×FY 2021: -8.0×FY 2022: -1.9×FY 2023: -2.4×FY 2024: -1.5×FY 2025: -1.1×
FY 2016 5y median -1.9× FY 2025
P/S 1.1×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 82.8×FY 2019: 101×FY 2020: 114×FY 2021: 23.7×FY 2022: 81.6×FY 2023: 22.0×FY 2024: 6.6×FY 2025: 1.1×
FY 2016 5y median 22.0× FY 2025
P/B 1.1×
FY 2016: 15.8×FY 2017: 3.9×FY 2018: 2.8×FY 2019: 6.4×FY 2020: 4.5×FY 2021: 5.4×FY 2022: 1.5×FY 2023: 3.3×FY 2024: 3.5×FY 2025: 1.1×
FY 2016 5y median 3.3× FY 2025
P/FCF -1.3×
FY 2016: -37.0×FY 2017: -17.9×FY 2018: -3.3×FY 2019: -11.3×FY 2020: -10.8×FY 2021: -8.9×FY 2022: -2.4×FY 2023: -3.0×FY 2024: -1.7×FY 2025: -1.3×
FY 2016 5y median -2.4× FY 2025
EV/EBITDA -0.2×
FY 2016: -30.2×FY 2017: -7.8×FY 2018: -1.9×FY 2019: -8.7×FY 2020: -6.6×FY 2021: -6.6×FY 2022: -1.4×FY 2023: -1.9×FY 2024: -1.3×FY 2025: -0.2×
FY 2016 5y median -1.4× FY 2025
EV/Sales 0.2×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 64.6×FY 2019: 90.0×FY 2020: 92.3×FY 2021: 20.2×FY 2022: 55.7×FY 2023: 15.8×FY 2024: 5.1×FY 2025: 0.2×
FY 2016 5y median 15.8× FY 2025
FCF Yield -75.6%
FY 2016: -2.7%FY 2017: -5.6%FY 2018: -29.9%FY 2019: -8.8%FY 2020: -9.2%FY 2021: -11.2%FY 2022: -41.3%FY 2023: -33.1%FY 2024: -59.3%FY 2025: -75.6%
FY 2016 5y median -41.3% FY 2025

Profitability

Gross Margin 100.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: -2398.2%FY 2019: -694.8%FY 2020: -963.5%FY 2021: 111.9%FY 2022: 100.0%FY 2023: -593.9%FY 2024: 100.0%FY 2025: 100.0%
FY 2016 5y median 100.0% FY 2025
Operating Margin -96.6%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: -3386.7%FY 2019: -1063.2%FY 2020: -1428.0%FY 2021: -292.6%FY 2022: -4275.1%FY 2023: -949.9%FY 2024: -446.9%FY 2025: -96.6%
FY 2016 5y median -446.9% FY 2025
Net Margin -96.9%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: -3411.5%FY 2019: -1061.2%FY 2020: -1419.8%FY 2021: -295.6%FY 2022: -4257.8%FY 2023: -924.1%FY 2024: -438.0%FY 2025: -96.9%
FY 2016 5y median -438.0% FY 2025
ROE -100.6%
FY 2016: -50.5%FY 2017: -37.7%FY 2018: -114.7%FY 2019: -67.2%FY 2020: -56.8%FY 2021: -67.4%FY 2022: -80.7%FY 2023: -136.8%FY 2024: -232.4%FY 2025: -100.6%
FY 2016 5y median -100.6% FY 2025
ROIC -86.6%
FY 2016: -50.3%FY 2017: -37.7%FY 2018: -98.9%FY 2019: -57.1%FY 2020: -51.2%FY 2021: -56.4%FY 2022: -62.6%FY 2023: -100.7%FY 2024: -157.3%FY 2025: -86.6%
FY 2016 5y median -86.6% FY 2025
ROA -63.0%
FY 2016: -47.0%FY 2017: -34.7%FY 2018: -85.9%FY 2019: -51.3%FY 2020: -45.0%FY 2021: -53.0%FY 2022: -58.1%FY 2023: -82.5%FY 2024: -126.4%FY 2025: -63.0%
FY 2016 5y median -63.0% FY 2025

Growth (YoY)

Revenue 195.7%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 202.7%FY 2020: -8.8%FY 2021: 373.7%FY 2022: -91.7%FY 2023: 341.0%FY 2024: 69.2%FY 2025: 195.7%
FY 2016 FY 2025
Operating Income 36.1%
FY 2016: -297.1%FY 2017: -203.4%FY 2018: -66.6%FY 2019: 5.0%FY 2020: -22.5%FY 2021: 3.0%FY 2022: -21.8%FY 2023: 2.0%FY 2024: 20.4%FY 2025: 36.1%
FY 2016 FY 2025
EPS (diluted) 61.1%
FY 2016: -42.3%FY 2017: -205.4%FY 2018: -71.7%FY 2019: 14.4%FY 2020: 6.0%FY 2021: 9.6%FY 2022: -5.7%FY 2023: 25.5%FY 2024: 35.1%FY 2025: 61.1%
FY 2016 FY 2025
Free Cash Flow 39.9%
FY 2016: -168.9%FY 2017: -106.6%FY 2018: -111.0%FY 2019: -9.1%FY 2020: -7.3%FY 2021: -20.1%FY 2022: -5.6%FY 2023: 4.8%FY 2024: 8.9%FY 2025: 39.9%
FY 2016 FY 2025

Financial Health

Current Ratio 2.7×
FY 2016: 14.2×FY 2017: 12.2×FY 2018: 6.5×FY 2019: 5.2×FY 2020: 5.4×FY 2021: 5.4×FY 2022: 6.7×FY 2023: 3.0×FY 2024: 1.8×FY 2025: 2.7×
FY 2016 5y median 3.0× FY 2025
Quick Ratio 2.7×
FY 2016: 14.2×FY 2017: 12.1×FY 2018: 6.5×FY 2019: 5.2×FY 2020: 5.4×FY 2021: 5.4×FY 2022: 6.7×FY 2023: 3.0×FY 2024: 1.8×FY 2025: 2.7×
FY 2016 5y median 3.0× FY 2025
Debt / Equity 0.2×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.1×FY 2020: 0.1×FY 2021: 0.2×FY 2022: 0.3×FY 2023: 0.4×FY 2024: 0.5×FY 2025: 0.2×
FY 2016 5y median 0.3× FY 2025
Net Debt / EBITDA 0.9×
FY 2016: 2.0×FY 2017: 2.7×FY 2018: 0.5×FY 2019: 1.1×FY 2020: 1.5×FY 2021: 1.2×FY 2022: 0.6×FY 2023: 0.7×FY 2024: 0.4×FY 2025: 0.9×
FY 2016 5y median 0.7× FY 2025
Interest Coverage -74.3×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: -74.6×FY 2023: -41.9×FY 2024: -52.1×FY 2025: -74.3×
FY 2016 5y median -52.1× FY 2025

Dividends

Dividend Yield 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31